Terms: = Breast cancer AND IDH2, P48735, 3418, ENSG00000182054, IDHM, mNADP-IDH, IDH, IDP, ICD-M
163 results:
1. Wild-type idh2 is a therapeutic target for triple-negative breast cancer.
Li JJ; Yu T; Zeng P; Tian J; Liu P; Qiao S; Wen S; Hu Y; Liu Q; Lu W; Zhang H; Huang P
Nat Commun; 2024 Apr; 15(1):3445. PubMed ID: 38658533
[TBL] [Abstract] [Full Text] [Related]
2. Cyclic-NDGA Effectively Inhibits Human γ-Synuclein Fibrillation, Forms Nontoxic Off-Pathway Species, and Disintegrates Preformed Mature Fibrils.
Singh SL; Bhat R
ACS Chem Neurosci; 2024 May; 15(9):1770-1786. PubMed ID: 38637513
[TBL] [Abstract] [Full Text] [Related]
3. Treatment Strategy for breast Benign Intraductal Papilloma: A Meta-Analysis.
Lou C; Wang W; Zhou B
J Environ Pathol Toxicol Oncol; 2024; 43(3):39-49. PubMed ID: 38608144
[TBL] [Abstract] [Full Text] [Related]
4. OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway.
Ci M; Zhao G; Li C; Liu R; Hu X; Pan J; Shen Y; Zhang G; Li Y; Zhang L; Liang P; Cui H
Cell Death Dis; 2024 Mar; 15(3):179. PubMed ID: 38429268
[TBL] [Abstract] [Full Text] [Related]
5. Isocitrate dehydrogenase 2 regulates the proliferation of triple-negative breast cancer through the ferroptosis pathway.
Zhang C; Zhou Y; Chen T; Bhushan S; Sun S; Zhang P; Yang Y
Sci Rep; 2024 Feb; 14(1):4732. PubMed ID: 38413708
[TBL] [Abstract] [Full Text] [Related]
6. Malignant upgrade rate and associated clinicopathologic predictors for concordant intraductal papilloma without atypia: A systematic review and meta-analysis.
Keating N; Cevik J; Hopkins D; Lippey J
J Surg Oncol; 2024 May; 129(6):1025-1033. PubMed ID: 38305061
[TBL] [Abstract] [Full Text] [Related]
7. MRPS23 is a novel prognostic biomarker and promotes glioma progression.
Wang Q; Chen G; Liu L; Peng X; Yang X; Yang L; Li C
Aging (Albany NY); 2024 Jan; 16(3):2457-2474. PubMed ID: 38301044
[TBL] [Abstract] [Full Text] [Related]
8. Imprint Cytology of Tall Cell Carcinoma with Reversed Polarity of the breast: A Case Report.
Shinomiya Y; Kouchi Y; Onodera K; Yamamoto H; Harada-Kagitani S; Sakakibara J; Nagashima T; Ikeda JI; Kishimoto T
Acta Cytol; 2024; 68(1):73-79. PubMed ID: 38262369
[TBL] [Abstract] [Full Text] [Related]
9. LINC00571 drives tricarboxylic acid cycle metabolism in triple-negative breast cancer through HNRNPK/ILF2/idh2 axis.
Xi Z; Huang H; Hu J; Yu Y; Ma X; Xu M; Ming J; Li L; Zhang H; Chen H; Huang T
J Exp Clin Cancer Res; 2024 Jan; 43(1):22. PubMed ID: 38238853
[TBL] [Abstract] [Full Text] [Related]
10. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
11. BCL2A1 is associated with tumor-associated macrophages and unfavorable prognosis in human gliomas.
Gao L; Ye Z; Peng S; Lei P; Song P; Li Z; Zhou L; Hua Q; Cheng L; Wei H; Liu J; Cai Q
Aging (Albany NY); 2023 Oct; 15(20):11611-11638. PubMed ID: 37889551
[TBL] [Abstract] [Full Text] [Related]
12. Tumor-to-tumor metastasis of an adenocarcinoma to a glioblastoma with review of the literature on tumor-to-tumor metastasis to gliomas.
Galev G; Weigelt MA; Prayson RA
Clin Neuropathol; 2023; 42(5):190-196. PubMed ID: 37779445
[TBL] [Abstract] [Full Text] [Related]
13. Mismatch repair-deficient glioma with spatially distinct idh-mutant and idh-wild type components arising in the setting of Lynch syndrome.
Tan H; Nerison C; Stateler C; Bowden SG; Raslan AM; Ambady P; Barajas RF; Wood MD
Cold Spring Harb Mol Case Stud; 2023 Apr; 9(2):. PubMed ID: 37076313
[TBL] [Abstract] [Full Text] [Related]
14. Occurrence of non-central nervous system cancers during postoperative follow-up of patients who underwent surgery for a WHO grade II glioma: implications for therapeutic management.
Duffau H
J Neurooncol; 2023 Mar; 162(1):237-244. PubMed ID: 36913047
[TBL] [Abstract] [Full Text] [Related]
15. Incidence of antibody-drug conjugates-related pneumonitis in patients with solid tumors: A systematic review and meta-analysis.
Zhu Z; Shen G; Li J; Qiu T; Fang Q; Zheng Y; Xin Y; Liu Z; Zhao F; Ren D; Zhao J
Crit Rev Oncol Hematol; 2023 Apr; 184():103960. PubMed ID: 36907365
[TBL] [Abstract] [Full Text] [Related]
16. Risk of seizures in a population of women with BRCA-positive metastatic breast cancer from an electronic health record database in the United States.
Liede A; Sebby W; Miriyala AKR; Potluri R; Mazumder D; Ghosh A; Papademetriou E; Kilpatrick R; Tyczynski JE
BMC Cancer; 2023 Jan; 23(1):78. PubMed ID: 36690978
[TBL] [Abstract] [Full Text] [Related]
17. Recurrent idh2 Mutations in Salivary Gland Striated Duct Adenoma Define an Expanded Histologic Spectrum Distinct From Canalicular Adenoma.
Rooper LM; Agaimy A; Assaad A; Bal M; Eugene H; Gagan J; Nonogaki H; Palsgrove DN; Shah A; Stelow E; Stoehr R; Thompson LDR; Weinreb I; Bishop JA
Am J Surg Pathol; 2023 Mar; 47(3):333-343. PubMed ID: 36510691
[TBL] [Abstract] [Full Text] [Related]
18. Intraductal Papillomas.
Tierney SN
Surg Clin North Am; 2022 Dec; 102(6):965-972. PubMed ID: 36335931
[TBL] [Abstract] [Full Text] [Related]
19. Intrinsic Disorder in BAP1 and Its Association with Uveal Melanoma.
Djulbegovic MB; Taylor DJ; Uversky VN; Galor A; Shields CL; Karp CL
Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292588
[TBL] [Abstract] [Full Text] [Related]
20. The Diagnostic Utility of idh2 R172 Immunohistochemistry in Tall Cell Carcinoma With Reversed Polarity of the breast.
Sasaki E; Iwakoshi A; Satake T; Nakajima K; Kobayashi M; Ando Y; Koshikawa T; Masago K; Honma N; Nishimura R; Kato Y; Ichihara S
Appl Immunohistochem Mol Morphol; 2022 Nov-Dec 01; 30(10):654-661. PubMed ID: 36222504
[TBL] [Abstract] [Full Text] [Related]
[Next]
